The future of medicine is light.

A wave of light can be tuned to reach one kind of cell and leave its neighbors untouched. C Laser is building on that idea with LILA®, a low-intensity laser designed to quiet chronic pain at the nerve, without heat and without drugs.

LILA® is in development. It has not been approved or cleared by the U.S. FDA.

Scroll

How light heals

Medicine already heals with light.

Blue light clears jaundice in newborns. Green laser light seals a torn retina. Deep-red light activates a drug that closes leaking vessels at the back of the eye.

Each works for the same reason. The wavelength is chosen so that the target absorbs it and the tissue around it does not.

  • 460 nmNewborn jaundice
  • 532 nmRetinal tears
  • 689 nmMacular degeneration

The target

Chronic pain travels on the body’s thinnest fibers.

A nerve carries two very different kinds of traffic. Thick fibers, wrapped in an insulating sheath called myelin, carry touch, movement and sharp, protective pain.

Thin, bare C-fibers, about a thousandth of a millimeter across, carry the slow, dull ache that can persist long after an injury has healed.

  • Myelinated fibersTouch and movement
  • C-fibersSlow, persistent pain

The LILA approach

Light tuned to the fiber, designed to spare the rest.

Light acts only where it is absorbed, and what absorbs it depends on the wavelength. That is the principle LILA® is built on.

LILA® is designed to deliver deep-red light, in pulses that last billionths of a second, to the thin fibers that carry chronic pain, and to leave the insulated fibers beside them working.

Whether LILA® achieves this selectivity in patients has not been established. Demonstrating it is the purpose of the company’s clinical program.

Delivery

Through a fine needle, in a few seconds.

The light travels down an optical fiber fixed inside a 25-gauge needle. A physician guides the tip to the source of the pain, and the laser runs for five to ten seconds at each site.

The system is designed to work without heating tissue, without an incision and with the patient awake.

Needle
25 gauge
Optical fiber
300 µm
Light per site
5–10 s

The technology

Three settings define the LILA® system.

LILA stands for Low Intensity Laser Ablation. The system, known as Srilas 7, pairs a compact pulsed-laser console with a needle that carries an optical fiber to the treatment site.

  1. Wavelength

    705 nanometers

    Deep red, at the edge of what the eye can see. The wavelength was selected with the aim of acting on unmyelinated nerve fibers.

  2. Pulse

    Billionths of a second

    The light arrives in nanosecond pulses rather than as a continuous beam, so each burst is over almost as soon as it begins.

  3. Power

    3.6 milliwatts

    The laser’s maximum output is 3.6 thousandths of a watt. Lasers that cut or coagulate tissue typically operate at a tenth of a watt or more. LILA® is designed to act without heat.

System specifications

Wavelength
705 nm (± 2 nm)
Emission
Pulsed, nanosecond range
Maximum output power
3.6 mW
Optical fiber
300 µm core
Needle
25 gauge
Exposure
5 to 10 seconds per site

As described in C Laser’s regulatory submissions and U.S. patents. LILA® and the Srilas 7 system have not been approved or cleared by the U.S. Food and Drug Administration. Their safety and effectiveness have not been established.

The science

Light has been healing for more than a century.

Using light as treatment is not new. What has changed is how precisely it can be made, pulsed and delivered.

  1. 1903

    Niels Finsen receives the Nobel Prize in Medicine for treating tuberculosis of the skin with concentrated light.

  2. 1958

    Physicians in England show that blue light clears jaundice in newborns. Phototherapy is still standard care.

  3. 1960

    Theodore Maiman builds the first working laser.

  4. 1961

    An ophthalmologist in New York treats a patient with a laser for the first time, destroying a tumor of the retina.

  5. 2018

    The Nobel Prize in Physics honors the ultrashort laser pulses now used in millions of eye surgeries each year.

  6. Next

    Chronic pain. The question C Laser is working to answer.

Where LILA® stands

What has been explored

Early laboratory and animal studies, carried out with university collaborators, examined how nerve tissue responds to LILA’s light. The system has also been used in early, uncontrolled clinical work at a single pain center. This early work does not establish safety or effectiveness.

What comes next

LILA® has not yet been tested in a randomized, controlled, multicenter study. That study, run by independent investigators, is the work ahead.

Company

Built around one question: can light quiet a pain nerve without burning it?

C Laser Inc. is a medical device company based in Clearwater, Florida. It works in biophotonics, the science of using light in living tissue, and its lead program is LILA®.

The company was founded by Pattanam Srinivasan, MD, a board-certified anesthesiologist and pain physician who invented the LILA method. The method, its laser generator and its fiber-carrying needle are described in U.S. patents issued to C Laser Inc.

Today the company’s work centers on the clinical evidence needed to bring LILA® to patients.

Headquarters
Clearwater, Florida
Field
Biophotonics
Lead program
LILA®
Stage
In development

Help us find out what light can do.

We welcome conversations with clinical investigators, research institutions and development partners.

Write to C Laser srinidoc@claser.us